StockData
BNRNasdaqServices-Medical Laboratories

Burning Rock Biotech Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026
$12.29−0.61 (-4.73%)

Close on Oct 19, 2026

Burning Rock Biotech Ltd revenue by segment

No segment breakdown reported

Burning Rock Biotech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.